The LYNKYTO brand, founded in 2015 (United States), from 7 sister brands. LYNKYTO is owned by Celldex Therapeutics, listed on the stock exchange of New York LYNKYTO is part of the Divers activity sector.
Share price and profitability of the share Celldex Therapeutics (LYNKYTO)
Buy Celldex Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Stock market history Celldex Therapeutics (LYNKYTO)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
